U.S. market Closed. Opens in 5 hours 51 minutes

AMED | Amedisys, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 95.11 - 95.58
52 Week Range 89.55 - 98.95
Beta 0.77
Implied Volatility 28.95%
IV Rank 70.91%
Day's Volume 208,925
Average Volume 359,704
Shares Outstanding 32,740,600
Market Cap 3,123,125,834
Sector Healthcare
Industry Medical - Care Facilities
IPO Date 1994-08-17
Valuation
Profitability
Growth
Health
P/E Ratio 33.95
Forward P/E Ratio N/A
EPS 2.81
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 19,000
Country USA
Website AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
AMED's peers: ACHC, ADUS, AGL, AIRS, EHC, ENSG, OPCH, UHS, SGRY, EHAB, PNTG, INNV, NHC, HCSG, AMN, AMS, ATIP, CMPS, DVA, HCA, BACK
*Chart delayed
Analyzing fundamentals for AMED we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is on medium level and Health is passable. For more detailed analysis please see AMED Fundamentals page.

Watching at AMED technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on AMED Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙